Among these, AOH1996, a first-in-class small-molecule PCNA inhibitor, selectively targets cancer-associated PCNA isoforms, effectively impairing DNA replication and repair in tumor cells while sparing normal cells (Gu et al., 2023b). Here, PCNA is linked to neoplasm.